Centauri Therapeutics Funding: $38M Raised, Series A (2022)
Centauri Therapeutics is based in London, England. It has raised $38M in total funding. Latest round: Series A.
Centauri Therapeutics funding overview
Centauri Therapeutics is based in London, England. Centauri Therapeutics has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2022. The round record for Centauri Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Boehringer Ingelheim Venture Fund, Evotec SE, Novo Holdings REPAIR Impact Fund, AMR Action Fund. 4 distinct backers are named across the disclosed rounds.
Centauri Therapeutics at a glance
Total raised
$38M
Latest round
Series A
Latest round date
July 2022
Headquarters
London, England
Notable investors
Boehringer Ingelheim Venture Fund, Evotec SE, Novo Holdings REPAIR Impact Fund, AMR Action Fund
Frequently asked about Centauri Therapeutics funding
How much has Centauri Therapeutics raised?
Centauri Therapeutics has raised $38M in total disclosed funding across the rounds on record.
Who has invested in Centauri Therapeutics?
Boehringer Ingelheim Venture Fund, Evotec SE, Novo Holdings REPAIR Impact Fund, AMR Action Fund are named among the investors backing Centauri Therapeutics.
What was the latest Centauri Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2022.
Where is Centauri Therapeutics based?
Centauri Therapeutics is based in London, England.
When did Centauri Therapeutics last raise?
The last disclosed Centauri Therapeutics round closed in July 2022 at Series A.
Centauri Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in London below to benchmark round size and investor mix.
